Clinical Trial

Modulating Immunosuppression by Alveolar Efferocytosis

Study Description

Modulation of Steroid Immunosuppression by Alveolar Efferocytosis

The long-term goals of this study are (a) to understand the biological underpinnings for the increased incidence of community-acquired pneumonia in patients with chronic obstructive pulmonary disease (COPD) who are treated with inhaled corticosteroids; and (b) to develop novel therapies to treated this problem using over-expression of micro-RNAs (miRNAs).

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Procedure - Bronchoscopy with bilateral bronchoalveolar lavages

Bronchoscopy with bilateral bronchoalveolar lavages

Additional Information

Official Study Title

Modulation of Steroid Immunosuppression by Alveolar Efferocytosis

Clinical Trial ID

NCT03034642

ParticipAid ID

zbqm0b